Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-27T03:50:55.219Z Has data issue: false hasContentIssue false

Chapter 16 - Myeloproliferative Neoplasms

from Section IV - Precursor Hematopoietic Neoplasms and Related Neoplasms

Published online by Cambridge University Press:  25 November 2023

Silvia Tse Bunting
Affiliation:
Cleveland Clinic Florida Weston
Xiayuan Liang
Affiliation:
University of Colorado
Michele E. Paessler
Affiliation:
University of Pennsylvania School of Medicine
Satheesh Chonat
Affiliation:
Emory University, Atlanta
Get access

Summary

Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders characterized by a proliferation of one or more of the myeloid lineages [1]. These components include erythroid cells, megakaryocytes, and granulocytes, the latter of which include eosinophils. In many cases, these MPNs are associated with acquired clonal genetic abnormalities involving cytoplasmic or receptor protein tyrosine kinases.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arber, DA, Orazi, A, Hasserjian, RP, Brunning, RD, Le Beau, MM, Porwit, A, et al. Introduction and overview of the classification of myeloid neoplasms. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017:1627.Google Scholar
Vardiman, JW, Melo, JV, Baccarani, M, Radich, JP, Kvasnicka, HM. Chronic myeloid leukaemia, BCR-ABL1-positive. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017:30–6.Google Scholar
Ianotto, JC, Curto-Garcia, N, Lauermanova, M, Radia, D, Kiladjian, JJ, Harrison, CN. Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: A systematic review. Haematologica. 2019; 104(8): 1580–8.CrossRefGoogle ScholarPubMed
Thiele, J, Kvasnicka, HM, Orazi, A, Gianelli, U, Tefferi, A, Gisslinger, H, et al. Essential thrombocythaemia. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017:50–3.Google Scholar
Kucine, N, Al-Kawaaz, M, Hajje, D, Bussel, J, Orazi, A. Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms. Br J Haematol. 2019; 185(1): 136–9.CrossRefGoogle ScholarPubMed
Giona, F, Teofili, L, Capodimonti, S, Laurino, M, Martini, M, Marzella, D, et al. CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence. Blood. 2014; 123(23): 3677–9.CrossRefGoogle ScholarPubMed
Giona, F, Teofili, L, Moleti, ML, Martini, M, Palumbo, G, Amendola, A, et al. Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: Clinical and biologic features, treatment, and long-term outcome. Blood. 2012; 119(10): 2219–27.CrossRefGoogle ScholarPubMed
Thiele, J, Kvasnicka, HM, Orazi, A, Tefferi, A, Birgegard, G, Barbui, T. Polycythaemia vera. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017:3943.Google Scholar
Teofili, L, Giona, F, Martini, M, Cenci, T, Guidi, F, Torti, L, et al. The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia. Blood. 2007; 110(9): 3384–6.CrossRefGoogle Scholar
Karow, A, Nienhold, R, Lundberg, P, Peroni, E, Putti, MC, Randi, ML, et al. Mutational profile of childhood myeloproliferative neoplasms. Leukemia. 2015; 29(12): 2407–9.CrossRefGoogle ScholarPubMed
Teofili, L, Giona, F, Martini, M, Cenci, T, Guidi, F, Torti, L, et al. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol. 2007; 25(9): 1048–53.CrossRefGoogle ScholarPubMed
Thiele, J, Kvasnicka, HM, Orazi, A, Gianelli, U, Barbui, T, Barosi, G, et al. Primary myelofibrosis. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017:4450.Google Scholar
DeLario, MR, Sheehan, AM, Ataya, R, Bertuch, AA, Vega, C, 2nd, Webb, CR, et al. Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis: An entity different from adults. Am J Hematol. 2012; 87(5): 461–4.CrossRefGoogle ScholarPubMed
An, W, Wan, Y, Guo, Y, Chen, X, Ren, Y, Zhang, J, et al. CALR mutation screening in pediatric primary myelofibrosis. Pediatr Blood Cancer. 2014; 61(12): 2256–62.CrossRefGoogle ScholarPubMed
Druhan, LJ, McMahon, DP, Steuerwald, N, Price, AE, Lance, A, Gerber, JM, et al. Chronic neutrophilic leukemia in a child with a CSF3 R T618I germ line mutation. Blood. 2016; 128(16): 2097–9.CrossRefGoogle Scholar
Hasle, H. Incidence of essential thrombocythaemia in children. Br J Haematol. 2000; 110(3): 751.CrossRefGoogle ScholarPubMed
Uygun, V, Daloglu, H, Ozturkmen, S, Karasu, G, Avci, Z, Yesilipek, A. Chronic neutrophilic leukemia, an extremely rare cause of neutrophilia in childhood: Cure with hematopoietic stem cell transplantation. Pediatr Transplant. 2018; 22(5): e13199.CrossRefGoogle ScholarPubMed
Bain, BJ, Brunning, RD, Orazi, A, Thiele, J. Chronic neutrophilic leukaemia. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017:37–8.Google Scholar
Kvasnicka, HM, Thiele, J, Orazi, A, Horny, H-P, Bain, BJ. Myeloproliferative neoplasm, unclassifiable. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2017:57–9.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×